Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease - Ondo, William G.; Tintner, Ron; Dat Voung, Kevin; Lai, Dejian; Ringholz, George (Movement disorders, 2005)
Keywords: Adult; Aged; Aged, 80 and over; Antipsychotic Agents - adverse effects; Biological and medical sciences; Brief Psychiatric Rating Scale; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Dibenzothiazepines - adverse effects; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug toxicity and drugs side effects treatment; Female; hallucinations; Hallucinations - chemically induced; Humans; Male; Medical sciences; Middle Aged; Neurology; Neuropsychological Tests; Parkinson Disease - drug therapy; Parkinson's disease; Pharmacology. Drug treatments; Placebos; psychosis; quetiapine; Quetiapine Fumarate; Surveys and Questionnaires; Toxicity: nervous system and muscle; Treatment Outcome; Psychosis; Nervous system diseases; Parkinson's disease; Hallucination; Central nervous system disease; Placebo; Parkinson disease; Degenerative disease; hallucinations; Quetiapine; Cerebral disorder; Extrapyramidal syndrome